Sign In
Buy MEDP
$450.82
+5.23 (+1.17%)
At Close: Jun 03, 2026
NEW YORK, NY / ACCESSWIRE / July 31, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violation
MEDP Investors Can Join The Medpace Holdings Inc Securities Fraud Investigation With The Schall Law Firm
08:45am, Wednesday, 31'st Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings,
Lost Money on Medpace Holdings, Inc. (MEDP)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
08:45am, Tuesday, 30'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violation
MEDP Investors Can Participate In The Medpace Holdings, Inc. Securities Fraud Investigation With The Schall Law Firm
08:30am, Tuesday, 30'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings,
Medpace Holdings, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - MEDP
07:25am, Tuesday, 30'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violation
Medpace Holdings, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - MEDP
07:25am, Monday, 29'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violation
Medpace Being Investigated on Behalf of Medpace Holdings, Inc. Investors. Contact Levi & Korsinsky For Details.
07:30am, Friday, 26'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violation
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violation
3 Reasons Growth Investors Will Love Medpace (MEDP)
01:45pm, Wednesday, 24'th Jul 2024
Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
MEDP ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Medpace Holdings, Inc. investment
04:00pm, Tuesday, 23'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace") (NASDAQ:MEDP) concerning possible violation
NXP Semiconductors Posts Mixed Q2 Results, Joins Medpace And Other Big Stocks Moving Lower In Tuesday Pre-Market Session
08:05am, Tuesday, 23'rd Jul 2024
U.S. stock futures were mixed this morning, with the Dow futures gaining around 20 points on Tuesday.
Medpace (MEDP) Tops Q2 Earnings Estimates
06:25pm, Monday, 22'nd Jul 2024
Medpace (MEDP) came out with quarterly earnings of $2.75 per share, beating the Zacks Consensus Estimate of $2.52 per share. This compares to earnings of $1.93 per share a year ago.
Backlog Conversion Likely to Aid Medpace's (MEDP) Q2 Earnings
12:50pm, Friday, 19'th Jul 2024
Continued strength in backlog conversion rate is likely to have boosted Medpace's (MEDP) top line in the second quarter.
Top Stocks to Buy for Growth as Earnings Approach
08:45pm, Thursday, 18'th Jul 2024
Investors will want to pay attention to several top-rated Zacks stocks that are set to report their quarterly results on Monday, July 22.
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
10:20am, Thursday, 18'th Jul 2024
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
